Everolimus plus exemestane for hormone resistant metastatic breast cancer (MBC): A single institutional experience.

被引：0
|
作者：
Foltran, Luisa
Bertola, Manuela
Del Conte, Alessandro
Lo Re, Giovanni
Bestetti, Alessandro
Sandri, Paolo
Saracchini, Silvana
机构：
[1] Gen Hosp, Dept Oncol, Pordenone, Italy
[2] Gen Hosp S Maria Angeli, Dept Oncol, Pordenone, Italy
[3] Santa Maria Angeli Hosp, Pordenone, Italy
[4] Santa Maria Angeli Gen Hosp, Pordenone, Italy
[5] S Maria Angeli, Pasiano Di Pordenone, PN, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e11576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11576
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy
    Cook, Madeline M.
    Al Rabadi, Luai
    Kaempf, Andy J.
    Saraceni, Megan M.
    Savin, Michael A.
    Mitri, Zahi I.
    ONCOLOGIST, 2021, 26 (02): : 101 - 106
  • [42] Are we improving the outcomes of metastatic breast cancer (MBC)? A single academic institution experience
    Florescu, A.
    Giilck, S.
    Victor, C.
    Zurawska, U.
    Baribeau, D. A.
    Verma, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] The effect of everolimus on body composition (BC) in patients with metastatic breast cancer (MBC).
    Baka, Nadia
    Phuong, Lisa
    Deng, Junwen
    Patel, Janki
    Goldman, Jessica
    Lyudmer, Michael
    Shamir, Stephanie
    Soto, Alvaro Alvarez
    Anampa Mesias, Jesus Del Santo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Incidence and management of toxicities associated with everolimus and exemestane (EVE plus EXE) in ER plus advanced breast cancer: The Royal Marsden experience
    Thanopoulou, E.
    Omarini, C.
    Patwari, S.
    Allen, M.
    Smith, I. E.
    Parton, M.
    O'Brien, M.
    Turner, N.
    Johnston, S. R. D.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S180 - S181
  • [45] An open-label study of sunitinib (SU) plus exemestane (E) in the first-line treatment of hormone receptor (HR)-positive metastatic breast cancer (MBC)
    Ahlgren, P.
    Thirlwell, M.
    O'Regan, R.
    Mormont, C.
    Levesque, L.
    Gaspo, R.
    Woloj, M.
    Bello, A.
    Martell, B.
    Leyland-Jones, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Efficacy and safety of everolimus and exemestane for metastatic breast cancer patients: a real-life experience of three Oncology Departments
    Meattini, I.
    Salvadori, B.
    Coltelli, L.
    Perna, M.
    Carta, G. A.
    Becherini, C.
    Grassi, R.
    Garlatti, P.
    Cappelli, S.
    Desideri, I.
    Vannini, A.
    Fontana, A.
    Landucci, E.
    Michelotti, A.
    Ricci, S.
    Allegrini, G.
    Falcone, A.
    Livi, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Trastuzumab plus paclitaxel in the treatment of advanced breast cancer: Single centre experience.
    Mrsic, M
    Bogdanic, V
    Labar, B
    Jakic-Razumovic, J
    ANNALS OF ONCOLOGY, 2000, 11 : 32 - 32
  • [48] Palbociclib in hormone positive metastatic breast cancer: A real world multicenter Indian experience.
    Rauthan, Amit
    Patil, Poonam
    Somashekhar, S. P.
    Jacob, Linu Abraham
    Lokanatha, D.
    Kumar, Kishore
    Keechilat, Pavithran
    Vijayakumar, D. K.
    Patil, Shekar
    Shashidhara, H. P.
    Zaveri, Shabber
    Yashas, Nitin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Predictive markers of everolimus efficacy in hormone receptor positive (HR plus ) metastatic breast cancer (MBC): Final results of the TAMRAD trial translational study.
    Treilleux, Isabelle
    Arnedos, Monica
    Cropet, Claire
    Ferrero, Jean-Marc
    Lacourtoisie, Sophie Abadie
    Spaeth, Dominique
    Levy, Christelle
    Legouffe, Eric
    Pujade-Lauraine, Eric
    Wang, Quing
    Bachelot, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience
    Assi, Tarek
    Kattan, Joseph
    El Rassy, Elie
    Tabchi, Samer
    Chebib, Ralph
    Moussa, Tania
    Hanna, Colette
    El Karak, Fadi
    Farhat, Fadi
    Ghosn, Marwan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (05) : 1112 - 1116
12345